Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

658 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation of the HepClink test-and-treat community strategy targeting Pakistani migrants with hepatitis C living in Catalonia (Spain) compared with the current practice of the Catalan health system: budget impact analysis.
Reyes-Urueña J, Costell-González F, Egea-Cortés L, Ouaarab H, Saludes V, Buti M, Majó I Roca X, Colom J, Gómez I Prat J, Casabona J, Martro E; HepClink Study Group. Reyes-Urueña J, et al. Among authors: buti m. BMJ Open. 2023 Aug 21;13(8):e068460. doi: 10.1136/bmjopen-2022-068460. BMJ Open. 2023. PMID: 37604632 Free PMC article.
OPTI-HEP-D: a protocol for an intervention study comprising screening and linkage to care of people living with hepatitis D in Catalonia.
Palom A, Rando-Segura A, Fernandez G, Calatayud L, Sellés-Sánchez A, Pérez Del Campo D, Mormeneo Bayo S, Perez Moreno MMO, Tabernero D, Ayats J, Llopis MA, Quer JC, Buti M. Palom A, et al. Among authors: buti m. BMJ Open. 2024 Nov 24;14(11):e086961. doi: 10.1136/bmjopen-2024-086961. BMJ Open. 2024. PMID: 39581731 Free PMC article.
Hepatitis E as a trigger for Acute-on-Chronic Liver Failure.
Buti M, Ruiz-Cobo JC, Esteban R, Riveiro-Barciela M. Buti M, et al. Clin Mol Hepatol. 2024 Nov 11. doi: 10.3350/cmh.2024.0758. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39523715 Free article. Review.
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.
Buti M, Lim YS, Chan HLY, Agarwal K, Marcellin P, Brunetto MR, Chuang WL, Janssen HLA, Fung SK, Izumi N, Jablkowski MS, Abdurakhmanov D, Abramov F, Wang H, Botros I, Yee LJ, Mateo R, Flaherty JF, Osinusi A, Pan CQ, Shalimar X, Seto WK, Gane EJ. Buti M, et al. Aliment Pharmacol Ther. 2024 Dec;60(11-12):1573-1586. doi: 10.1111/apt.18278. Epub 2024 Sep 27. Aliment Pharmacol Ther. 2024. PMID: 39327857 Free PMC article. Clinical Trial.
Implementing a new HCV model of care for people who use drugs.
Herranz Mochales A, Picchio CA, Nicolàs A, Macià MD, Fernández-Baca MV, Serrano J, Bonet L, Trelles M, Sansó A, Rubí AR, Zamora A, García-Gasalla M, Buti M, Vilella À, Lazarus JV. Herranz Mochales A, et al. Among authors: buti m. JHEP Rep. 2024 Jun 13;6(10):101145. doi: 10.1016/j.jhepr.2024.101145. eCollection 2024 Oct. JHEP Rep. 2024. PMID: 39308984 Free PMC article.
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B.
Buti M, Heo J, Tanaka Y, Andreone P, Atsukawa M, Cabezas J, Chak E, Coffin CS, Fujiwara K, Gankina N, Gordon SC, Janczewska E, Komori A, Lampertico P, McPherson S, Morozov V, Plesniak R, Poulin S, Ryan P, Sagalova O, Sheng G, Voloshina N, Xie Q, Yim HJ, Dixon S, Paff M, Felton L, Lee M, Greene T, Lim J, Lakshminarayanan D, McGonagle G, Plein H, Youssef AS, Elston R, Kendrick S, Theodore D. Buti M, et al. J Hepatol. 2025 Feb;82(2):222-234. doi: 10.1016/j.jhep.2024.08.010. Epub 2024 Aug 29. J Hepatol. 2025. PMID: 39214467 Free article. Clinical Trial.
658 results